Domača stranA • NYSE
add
Agilent Technologies
Prejšnji trg. dan.
137,00 $
Dnevni razpon
134,71 $ - 140,14 $
Letni razpon
124,16 $ - 155,35 $
Tržna kapitalizacija
39,21 mrd. USD
Povprečni obseg
1,63 mio.
Razm. P/E
31,03
Dividendna donosnost
0,72 %
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | okt. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 1,70 mrd. | 0,77 % |
Stroški poslovanja | 541,00 mio. | −28,91 % |
Čisti dohodek | 351,00 mio. | −26,11 % |
Čista dobičkovnost prihodkov | 20,63 | −26,69 % |
Earnings per share | 1,46 | 5,80 % |
EBITDA | 444,00 mio. | 105,56 % |
Efektivna davčna stopnja | 12,47 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | okt. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,33 mrd. | −16,42 % |
Skupna sredstva | 11,85 mrd. | 10,06 % |
Skupne obveznosti | 5,95 mrd. | 20,94 % |
Celoten lastniški kapital | 5,90 mrd. | — |
Shares outstanding | 285,60 mio. | — |
Razmerje P/B | 6,62 | — |
Donosnost sredstev | 8,21 % | — |
Donosnost kapitala | 10,14 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | okt. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 351,00 mio. | −26,11 % |
Denar iz dejavnosti | 481,00 mio. | −6,78 % |
Denar iz naložb | −954,00 mio. | −2.285,00 % |
Denar iz financiranja | 25,00 mio. | 112,44 % |
Neto sprememba denarnih sredstev | −450,00 mio. | −272,41 % |
Prost denarni tok | 277,38 mio. | 780,56 % |
Vizitka
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting IPO of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government markets. Wikipedia
Generalni direktor
Datum ustanovitve
1999
Sedež organizacije
Spletno mesto
Zaposleni
17.900
